• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过比较基因组学鉴定脊髓性肌萎缩症的一个候选修饰基因。

Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics.

作者信息

Scharf J M, Endrizzi M G, Wetter A, Huang S, Thompson T G, Zerres K, Dietrich W F, Wirth B, Kunkel L M

机构信息

Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Nat Genet. 1998 Sep;20(1):83-6. doi: 10.1038/1753.

DOI:10.1038/1753
PMID:9731538
Abstract

Spinal muscular atrophy (SMA) is a common recessive disorder characterized by the loss of lower motor neurons in the spinal cord. The disease has been classified into three types based on age of onset and severity. SMA I-III all map to chromosome 5q13 (refs 2,3), and nearly all patients display deletions or gene conversions of the survival motor neuron (SMN1) gene. Some correlation has been established between SMN protein levels and disease course; nevertheless, the genetic basis for SMA phenotypic variability remains unclear, and it has been postulated that the loss of an additional modifying factor contributes to the severity of type I SMA. Using comparative genomics to screen for such a factor among evolutionarily conserved sequences between mouse and human, we have identified a novel transcript, H4F5, which lies closer to SMN1 than any previously identified gene in the region. A multi-copy microsatellite marker that is deleted in more than 90% of type I SMA chromosomes is embedded in an intron of this gene, indicating that H4F5 is also highly deleted in type I SMA chromosomes, and thus is a candidate phenotypic modifier for SMA.

摘要

脊髓性肌萎缩症(SMA)是一种常见的隐性疾病,其特征是脊髓中的下运动神经元丧失。根据发病年龄和严重程度,该疾病已被分为三种类型。SMA I - III型均定位于5号染色体q13区域(参考文献2,3),几乎所有患者都表现出存活运动神经元(SMN1)基因的缺失或基因转换。SMN蛋白水平与疾病进程之间已建立了一些相关性;然而,SMA表型变异性的遗传基础仍不清楚,据推测,另一个修饰因子的缺失会导致I型SMA的严重程度增加。通过比较基因组学在小鼠和人类之间进化保守序列中筛选这样一个因子,我们鉴定出了一种新的转录本H4F5,它在该区域比任何先前鉴定的基因更靠近SMN1。一种在超过90%的I型SMA染色体中缺失的多拷贝微卫星标记嵌入在该基因的一个内含子中,这表明H4F5在I型SMA染色体中也高度缺失,因此是SMA的一个候选表型修饰因子。

相似文献

1
Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics.通过比较基因组学鉴定脊髓性肌萎缩症的一个候选修饰基因。
Nat Genet. 1998 Sep;20(1):83-6. doi: 10.1038/1753.
2
Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.脊髓性肌萎缩症位点的传递比率失真:来自314例产前检测的数据。
Neurology. 2005 Nov 22;65(10):1631-5. doi: 10.1212/01.wnl.0000184506.61354.5b.
3
An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).常染色体隐性遗传性脊髓性肌萎缩症(SMA)中存活运动神经元基因(SMN1)突变谱的更新
Hum Mutat. 2000;15(3):228-37. doi: 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9.
4
High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.摩洛哥成年型脊髓性肌萎缩症患者中SMN1基因缺失的高发生率。
J Neurol. 2003 Oct;250(10):1209-13. doi: 10.1007/s00415-003-0186-1.
5
[Molecular basis of spinal muscular atrophy: th SMN gene].[脊髓性肌萎缩症的分子基础:SMN基因]
Neurologia. 2000 Nov;15(9):393-400.
6
Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.沙特脊髓性肌萎缩症患者脊髓性肌萎缩症及神经元凋亡抑制蛋白基因的分子分析
Saudi Med J. 2003 Oct;24(10):1052-4.
7
Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.存活运动神经元SMN1和SMN2基因启动子:序列相同但在神经元和非神经元细胞中表达不同。
Eur J Hum Genet. 2004 Sep;12(9):729-37. doi: 10.1038/sj.ejhg.5201217.
8
SMN oligomerization defect correlates with spinal muscular atrophy severity.SMN寡聚化缺陷与脊髓性肌萎缩症的严重程度相关。
Nat Genet. 1998 May;19(1):63-6. doi: 10.1038/ng0598-63.
9
Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations.无纯合SMN1缺失的脊髓性肌萎缩症患者的遗传学研究:复合杂合子的鉴定及新型基因内SMN1突变的特征分析
Hum Genet. 2002 Mar;110(3):257-63. doi: 10.1007/s00439-002-0681-y. Epub 2002 Feb 8.
10
A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.对西班牙脊髓性肌萎缩症患者进行的基因和表型分析,这些患者携带c.399_402del AGAG突变,这是SMN1基因中最常见的微小突变。
Hum Mutat. 2003 Aug;22(2):136-43. doi: 10.1002/humu.10245.

引用本文的文献

1
Long-read sequencing identifies copy-specific markers of SMN gene conversion in spinal muscular atrophy.长读长测序鉴定脊髓性肌萎缩症中SMN基因转换的拷贝特异性标记。
Genome Med. 2025 Mar 21;17(1):26. doi: 10.1186/s13073-025-01448-2.
2
In Search of Spinal Muscular Atrophy Disease Modifiers.寻找脊髓性肌萎缩症的修饰物。
Int J Mol Sci. 2024 Oct 18;25(20):11210. doi: 10.3390/ijms252011210.
3
Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1-3.中国1-3型5q脊髓性肌萎缩症患者生物标志物、表型与运动里程碑之间的关联
Front Neurol. 2024 Sep 2;15:1382410. doi: 10.3389/fneur.2024.1382410. eCollection 2024.
4
Dysregulation of innate immune signaling in animal models of spinal muscular atrophy.脊髓性肌萎缩症动物模型中固有免疫信号的失调。
BMC Biol. 2024 Apr 25;22(1):94. doi: 10.1186/s12915-024-01888-z.
5
Dysregulation of innate immune signaling in animal models of Spinal Muscular Atrophy.脊髓性肌萎缩症动物模型中固有免疫信号的失调。
bioRxiv. 2023 Dec 15:2023.12.14.571739. doi: 10.1101/2023.12.14.571739.
6
Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.淀粉样蛋白修饰物 SERF1a 通过螺旋相互作用与多聚谷氨酰胺扩展的 huntingtin-exon 1 相互作用,并加剧多聚谷氨酰胺诱导的毒性。
Commun Biol. 2023 Jul 21;6(1):767. doi: 10.1038/s42003-023-05142-0.
7
Genomic Variability in the Survival Motor Neuron Genes ( and ): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.生存运动神经元基因(和 )中的基因组变异性:对脊髓性肌萎缩症表型和治疗学发展的影响。
Int J Mol Sci. 2021 Jul 23;22(15):7896. doi: 10.3390/ijms22157896.
8
The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment.需要鉴定新型生物标志物以改善成人脊髓性肌萎缩症患者的分层、诊断和治疗。
J Pers Med. 2020 Jul 29;10(3):75. doi: 10.3390/jpm10030075.
9
Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report.脊髓性肌萎缩症(SMA)家系的基因组分析鉴定出生长分化因子 8(肌肉生长抑制素)激活剂 TLL2 的新突变:一例报告。
BMC Med Genet. 2019 Dec 30;20(1):204. doi: 10.1186/s12881-019-0935-3.
10
Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.参与脊髓性肌萎缩症通路的分子因素作为可能的疾病修饰候选因素。
Curr Genomics. 2018 Aug;19(5):339-355. doi: 10.2174/1389202919666180101154916.